# Integrative Assessment of Left Ventricular Myocardial Work: Prognostic Utility and Clinical Application Across Cardiovascular Pathologies

**Authors:** Alexandra-Cătălina Frișan, Mihai-Andrei Lazăr, Raluca Coifan, Simina Crișan, Daniel-Miron Brie, Silvia Ana Luca, Adina Ionac, Cristian Mornoș

PMC · DOI: 10.3390/jcm15031311 · Journal of Clinical Medicine · 2026-02-06

## TL;DR

This paper reviews how a new echocardiographic measure called left ventricular myocardial work improves risk assessment and clinical outcomes in various heart diseases.

## Contribution

The paper provides a comprehensive review of the prognostic value of myocardial work in cardiovascular pathologies.

## Key findings

- Myocardial work is associated with adverse outcomes like heart failure and mortality.
- Myocardial work offers a load-adjusted assessment of cardiac function.
- Myocardial work can be noninvasively estimated using commercial echocardiographic software.

## Abstract

Left ventricular myocardial work (MW) has emerged as a valuable echocardiographic parameter for evaluating cardiac function and predicting clinical outcomes. Unlike conventional indices such as left ventricular ejection fraction and global longitudinal strain, MW integrates myocardial deformation with left ventricular pressure, providing a load-adjusted and physiologically meaningful assessment of myocardial performance. Growing evidence demonstrates that impaired MW is consistently associated with adverse outcomes, including heart failure hospitalization, mortality, and functional deterioration, across a wide spectrum of cardiovascular conditions such as ischemic heart disease, valvular heart disease, and cardiomyopathies. The noninvasive estimation of MW using commercially available echocardiographic software has enhanced its feasibility in routine clinical practice, enabling improved risk stratification and early identification of high-risk patients. This review summarizes current evidence supporting the prognostic value of MW, highlights its incremental role beyond conventional echocardiographic parameters, and discusses future perspectives for its integration into everyday clinical decision-making.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), ischemic heart disease (MONDO:0024644), cardiomyopathies (MONDO:0004994)

## Full-text entities

- **Diseases:** impaired MW (MESH:D000073397), valvular heart disease (MESH:D006349), cardiovascular conditions (MESH:D002318), heart failure (MESH:D006333), cardiomyopathies (MESH:D009202), ischemic heart disease (MESH:D017202)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12897667/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12897667/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12897667/full.md

---
Source: https://tomesphere.com/paper/PMC12897667